[1]
Teoh, J.H.I. et al. 2022. COMPARISON OF THRICE-DAILY PREMIXED HUMAN INSULIN WITH BASAL- BOLUS THERAPY AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS. Journal of the ASEAN Federation of Endocrine Societies. 37, 2 (Oct. 2022), 48. DOI:https://doi.org/10.15605/jafes.037.AFES.73.